Market closedNon-fractional

Avid Bioservices/CDMO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Avid Bioservices

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.

Ticker

CDMO

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Tustin, United States

Employees

-

Avid Bioservices Metrics

BasicAdvanced
$490M
Market cap
-
P/E ratio
-$2.23
EPS
1.36
Beta
-
Dividend rate
$490M
1.36
1.474
0.951
336.727
341.333
-4.31%
-2.96%
-112.58%
3.478
7.99
7.99
-23.336
-6.27%
-55,026.11%
13.43%
239.50%

What the Analysts think about Avid Bioservices

Analyst Ratings

Majority rating from 5 analysts.
Buy

Avid Bioservices Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-17.75% profit margin
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$34M
-46.43%
Net income
-$6M
-48.28%
Profit margin
-17.75%
-3.43%

Avid Bioservices Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 71.43%
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
-
-$0.03
-$0.15
-$0.09
-
Expected
$0.00
-$0.03
-$0.06
-$0.05
-$0.04
Surprise
-
9.09%
140.00%
71.43%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Avid Bioservices stock?

Avid Bioservices (CDMO) has a market cap of $490M as of July 05, 2024.

What is the P/E ratio for Avid Bioservices stock?

The price to earnings (P/E) ratio for Avid Bioservices (CDMO) stock is 0 as of July 05, 2024.

Does Avid Bioservices stock pay dividends?

No, Avid Bioservices (CDMO) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Avid Bioservices dividend payment date?

Avid Bioservices (CDMO) stock does not pay dividends to its shareholders.

What is the beta indicator for Avid Bioservices?

Avid Bioservices (CDMO) has a beta rating of 1.36. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Avid Bioservices stock

Buy or sell Avid Bioservices stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing